美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IDEAYA Biosciences

28.19

-0.9100-3.13%

盤後：28.540.3500+1.24%19:54 EDT

成交量：89.65萬

成交額：2,540.45萬

市值：24.71億

市盈率：-21.94

高：29.40

開：29.02

低：28.16

收：29.10

52周最高：39.28

52周最低：16.82

股本：8,766.64萬

流通股本：8,181.61萬

量比：1.03

換手率：1.10%

股息：- -

股息率：- -

每股收益(TTM):-1.2849

每股收益(LYR):-1.2849

淨資產收益率：-10.92%

總資產收益率：-8.92%

市淨率：2.42

市盈率(LYR):-21.94

資料載入中...

總覽公司新聞資訊公告

IDEAYA Biosciences將於五月啓動RTOR申請，新藥上市申請預計2026年下半年完成

美國研究綜述-百健、Equinix、Revolution Medicines

美國研究綜述-百健、Equinix、Revolution Medicines

BUZZ--美國股票走勢-Allogene Therapeutics、Adobe、Williams-Sonoma

IDEAYA Biosciences飆漲逾40%！因眼癌藥物組合試驗達到主要目標並計劃提交新藥申請

BUZZ-眼癌藥物組合在試驗中提高了存活率，IDEAYA 生物科學公司股價大漲

IDEAYA與施維雅公布Darovasertib聯合克唑替尼一線治療HLA-A*02:01陰性轉移性葡萄膜黑色素瘤的2/3期註冊試驗（OPTIMUM-02）積極頂線結果

Ideaya眼癌藥物達到中後期試驗的主要目標

IDEAYA Biosciences計劃於2026年下半年提交新藥申請支持美國加速審批路徑

IDEAYA Biosciences臨床試驗達到主要終點 BICR評估顯示中位無進展生存期實現統計學顯著改善

IDEAYA Biosciences將於2026年4月13日公布轉移性葡萄膜黑色素瘤II/III期Optimum-02試驗頂線結果

IDEAYA Biosciences與阿斯利康達成臨床合作共同推進IDE849聯合Imfinzi治療小細胞肺癌研究

BUZZ-與阿斯利康達成肺癌藥物組合測試協議後，IDEAYA 公司股價上漲

IDEAYA Biosciences推進Ide849針對Dll3上調實體瘤的全球一期臨床試驗——SEC文件披露

IDEAYA Biosciences 達成協議評估Ide849聯合Imfinzi治療廣泛期小細胞肺癌

BUZZ--美國股票走勢-泰森食品公司、Atmus 過濾公司、安飛士預算公司

BUZZ--美國股票走勢-Soleno Therapeutics、Ideaya Biosciences、Profusa

BUZZ-早期癌症試驗啓動，IDEAYA 生物科學公司上漲

IDEAYA Biosciences宣佈啓動Ide574一期臨床試驗首例患者給藥，該潛在首創雙效抑制劑靶向乳腺癌、前列腺癌、結直腸癌及肺癌等多類實體瘤

BUZZ--美國股票走勢-能源股、礦商、Sysco

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IDYA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","market":"US","secType":"STK","nameCN":"IDEAYA Biosciences","latestPrice":28.19,"timestamp":1777665600000,"preClose":29.1,"halted":0,"volume":896480,"hourTrading":{"tag":"盘后","latestPrice":28.54,"preClose":28.19,"latestTime":"19:54 EDT","volume":54210,"amount":1533560.262,"timestamp":1777679660530,"change":0.35,"changeRate":0.012416,"amplitude":0.012416},"delay":0,"changeRate":-0.03127147766323024,"floatShares":81816082,"shares":87666408,"eps":-1.284937,"marketStatus":"休市中","change":-0.91,"latestTime":"05-01 16:00:00 EDT","open":29.02,"high":29.395,"low":28.16,"amount":25404468.1696,"amplitude":0.04244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.284937,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"listingDate":1558584000000,"exchange":"NASDAQ","adjPreClose":29.1,"preHourTrading":{"tag":"盘前","latestPrice":29.22,"preClose":29.1,"latestTime":"09:28 EDT","volume":8127,"amount":236498.54445,"timestamp":1777642080082,"change":0.12,"changeRate":0.004124,"amplitude":0.013402},"postHourTrading":{"tag":"盘后","latestPrice":28.54,"preClose":28.19,"latestTime":"19:54 EDT","volume":54210,"amount":1533560.262,"timestamp":1777679660530,"change":0.35,"changeRate":0.012416,"amplitude":0.012416},"volumeRatio":1.034442094771774,"impliedVol":0.5585,"impliedVolPercentile":0.247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","floatShares":81816082,"roa":"-8.92%","roe":"-10.92%","lyrEps":-1.284937,"volumeRatio":1.034442094771774,"shares":87666408,"dividePrice":0,"high":29.395,"amplitude":0.04244,"preClose":29.1,"low":28.16,"week52Low":16.82,"pbRate":"2.42","psRate":"11.30","week52High":39.28,"institutionHeld":0,"latestPrice":28.19,"eps":-1.284937,"divideRate":0,"volume":896480,"delay":0,"ttmEps":-1.284937,"open":29.02,"prevYearClose":34.57,"prevWeekClose":30.73,"prevMonthClose":29.1,"prevQuarterClose":33.32,"fiveDayClose":30.73,"twentyDayClose":32.74,"sixtyDayClose":33.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDYA\",params:#limit:5,,,undefined,":[{"date":"2026-02-17","symbol":"IDYA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771318800000,"name":null,"time":"盤前","dateTimestamp":1771304400000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"IDYA","fiscalQuarterEnding":"2025/09","expectedEps":0,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":1.33},{"market":"US","date":"2025-08-05","symbol":"IDYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.85,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-05-06","symbol":"IDYA","fiscalQuarterEnding":"2025/03","expectedEps":-0.75,"name":null,"time":"盤前","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.82},{"market":"US","date":"2025-02-13","symbol":"IDYA","fiscalQuarterEnding":"2024/12","expectedEps":-0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":-1.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1764043200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IDYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IDYA","date":"2026-05-01","current":-21.938819,"percent":0.252846,"low":-34.624829,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"high":-4.624403,"avg":-17.124961,"sd":7.700491,"marketCap":2555388185},"quantilePoints":[{"date":"2021-05-07","current":-18.288121,"twenty":-9.832451,"median":-5.324735,"eighty":-3.459277,"marketCap":630848747},{"date":"2021-05-14","current":-20.393803,"twenty":-10.104609,"median":-5.514956,"eighty":-3.464141,"marketCap":641854163},{"date":"2021-05-21","current":-21.240496,"twenty":-10.279775,"median":-5.63553,"eighty":-3.465219,"marketCap":668502132},{"date":"2021-05-28","current":-21.062795,"twenty":-10.625764,"median":-5.656499,"eighty":-3.474365,"marketCap":662909349},{"date":"2021-06-04","current":-20.989624,"twenty":-11.26273,"median":-5.676643,"eighty":-3.484294,"marketCap":660606438},{"date":"2021-06-11","current":-21.836317,"twenty":-12.053148,"median":-5.777074,"eighty":-3.496371,"marketCap":687254407},{"date":"2021-06-18","current":-23.717857,"twenty":-12.533769,"median":-5.971041,"eighty":-3.508471,"marketCap":746472115},{"date":"2021-06-25","current":-22.484403,"twenty":-12.898577,"median":-6.065403,"eighty":-3.513532,"marketCap":707651617},{"date":"2021-07-02","current":-23.059318,"twenty":-13.144678,"median":-6.217431,"eighty":-3.51557,"marketCap":725745917},{"date":"2021-07-09","current":-21.049231,"twenty":-13.370511,"median":-6.264612,"eighty":-3.517045,"marketCap":662482433},{"date":"2021-07-16","current":-22.691914,"twenty":-13.607926,"median":-7.020167,"eighty":-3.52146,"marketCap":714182615},{"date":"2021-07-23","current":-26.682771,"twenty":-13.783092,"median":-7.08007,"eighty":-3.524544,"marketCap":839786849},{"date":"2021-07-30","current":-29.809753,"twenty":-14.04946,"median":-7.153433,"eighty":-3.531687,"marketCap":938202363},{"date":"2021-08-06","current":-28.191509,"twenty":-14.587986,"median":-7.224561,"eighty":-3.533947,"marketCap":887271377},{"date":"2021-08-13","current":-29.97068,"twenty":-15.154018,"median":-7.242857,"eighty":-3.537369,"marketCap":899989535},{"date":"2021-08-20","current":-30.290333,"twenty":-16.287529,"median":-7.254477,"eighty":-3.541434,"marketCap":909588400},{"date":"2021-08-27","current":-29.305801,"twenty":-16.592186,"median":-7.303089,"eighty":-3.542962,"marketCap":880023897},{"date":"2021-09-03","current":-31.722379,"twenty":-16.958969,"median":-7.318795,"eighty":-3.549073,"marketCap":952591312},{"date":"2021-09-10","current":-33.985523,"twenty":-17.480455,"median":-7.331359,"eighty":-3.549073,"marketCap":1020551273},{"date":"2021-09-17","current":-34.343535,"twenty":-18.002071,"median":-7.384758,"eighty":-3.550496,"marketCap":1031302001},{"date":"2021-09-24","current":-32.451188,"twenty":-18.564804,"median":-7.425593,"eighty":-3.554316,"marketCap":974476724},{"date":"2021-10-01","current":-32.655766,"twenty":-19.003246,"median":-7.482701,"eighty":-3.556676,"marketCap":980619997},{"date":"2021-10-08","current":-32.70691,"twenty":-19.603951,"median":-7.576366,"eighty":-3.556676,"marketCap":982155815},{"date":"2021-10-15","current":-29.57431,"twenty":-19.948284,"median":-7.607522,"eighty":-3.556676,"marketCap":888086943},{"date":"2021-10-22","current":-29.305801,"twenty":-20.299726,"median":-7.64547,"eighty":-3.561126,"marketCap":880023897},{"date":"2021-10-29","current":-27.413454,"twenty":-20.498333,"median":-7.666222,"eighty":-3.5648,"marketCap":823198619},{"date":"2021-11-05","current":-30.149685,"twenty":-20.989624,"median":-7.758551,"eighty":-3.569714,"marketCap":905364899},{"date":"2021-11-12","current":-29.446448,"twenty":-21.062795,"median":-7.793103,"eighty":-3.570043,"marketCap":884247397},{"date":"2021-11-19","current":-24.362497,"twenty":-21.240496,"median":-7.827655,"eighty":-3.571919,"marketCap":893738217},{"date":"2021-11-26","current":-24.981527,"twenty":-21.39159,"median":-7.890477,"eighty":-3.574612,"marketCap":916447328},{"date":"2021-12-03","current":-23.145422,"twenty":-21.857223,"median":-7.96045,"eighty":-3.584136,"marketCap":849089797},{"date":"2021-12-10","current":-22.914597,"twenty":-22.068374,"median":-8.022404,"eighty":-3.586999,"marketCap":840621993},{"date":"2021-12-17","current":-22.841153,"twenty":-22.307678,"median":-8.080851,"eighty":-3.590242,"marketCap":837927691},{"date":"2021-12-23","current":-24.519878,"twenty":-22.478131,"median":-8.112599,"eighty":-3.600896,"marketCap":899511720},{"date":"2021-12-31","current":-24.803163,"twenty":-22.661484,"median":-8.124771,"eighty":-3.607486,"marketCap":909904025},{"date":"2022-01-07","current":-18.854181,"twenty":-22.696715,"median":-8.133171,"eighty":-3.607884,"marketCap":691665623},{"date":"2022-01-14","current":-18.6968,"twenty":-22.661484,"median":-8.166895,"eighty":-3.6108,"marketCap":685892120},{"date":"2022-01-21","current":-16.01084,"twenty":-22.62885,"median":-8.217153,"eighty":-3.61443,"marketCap":587357674},{"date":"2022-01-28","current":-16.304617,"twenty":-22.589226,"median":-8.232117,"eighty":-3.61955,"marketCap":598134879},{"date":"2022-02-04","current":-16.336093,"twenty":-22.528306,"median":-8.279975,"eighty":-3.626979,"marketCap":599289580},{"date":"2022-02-11","current":-15.95838,"twenty":-22.480222,"median":-8.317669,"eighty":-3.641021,"marketCap":585433173},{"date":"2022-02-18","current":-14.290147,"twenty":-22.452959,"median":-8.349952,"eighty":-3.663377,"marketCap":524234045},{"date":"2022-02-25","current":-14.300639,"twenty":-22.416661,"median":-8.361644,"eighty":-3.680345,"marketCap":524618945},{"date":"2022-03-04","current":-12.663882,"twenty":-22.374982,"median":-8.467308,"eighty":-3.689682,"marketCap":464574517},{"date":"2022-03-11","current":-13.4298,"twenty":-22.27281,"median":-8.578381,"eighty":-3.700816,"marketCap":492672230},{"date":"2022-03-18","current":-9.803903,"twenty":-22.210534,"median":-8.63295,"eighty":-3.710538,"marketCap":487861813},{"date":"2022-03-25","current":-8.880178,"twenty":-22.137363,"median":-8.648165,"eighty":-3.728362,"marketCap":441895419},{"date":"2022-04-01","current":-8.849128,"twenty":-22.038758,"median":-8.676953,"eighty":-3.732947,"marketCap":440350330},{"date":"2022-04-08","current":-8.771505,"twenty":-22.005987,"median":-8.686118,"eighty":-3.735526,"marketCap":436487608},{"date":"2022-04-14","current":-8.39891,"twenty":-21.980806,"median":-8.678356,"eighty":-3.739591,"marketCap":417946542},{"date":"2022-04-22","current":-8.297999,"twenty":-21.967416,"median":-8.654251,"eighty":-3.742674,"marketCap":412925003},{"date":"2022-04-29","current":-7.445176,"twenty":-21.940847,"median":-8.644345,"eighty":-3.747479,"marketCap":370486844},{"date":"2022-05-06","current":-7.080292,"twenty":-21.836317,"median":-8.631683,"eighty":-3.752283,"marketCap":352329512},{"date":"2022-05-13","current":-7.388684,"twenty":-21.606351,"median":-8.578381,"eighty":-3.771501,"marketCap":404559983},{"date":"2022-05-20","current":-7.762705,"twenty":-21.554086,"median":-8.467308,"eighty":-3.779737,"marketCap":425039142},{"date":"2022-05-27","current":-7.621565,"twenty":-21.406546,"median":-8.392554,"eighty":-3.780239,"marketCap":417311157},{"date":"2022-06-03","current":-8.397835,"twenty":-21.39159,"median":-8.36786,"eighty":-3.788369,"marketCap":459815071},{"date":"2022-06-10","current":-8.037928,"twenty":-21.387041,"median":-8.380207,"eighty":-3.794466,"marketCap":440108711},{"date":"2022-06-17","current":-8.729514,"twenty":-21.336664,"median":-8.392554,"eighty":-3.799547,"marketCap":477975835},{"date":"2022-06-24","current":-9.795122,"twenty":-21.273946,"median":-8.39891,"eighty":-3.80666,"marketCap":536322117},{"date":"2022-07-01","current":-10.10563,"twenty":-21.225131,"median":-8.471248,"eighty":-3.810725,"marketCap":553323683},{"date":"2022-07-08","current":-10.888958,"twenty":-21.198073,"median":-8.557964,"eighty":-3.815416,"marketCap":596213996},{"date":"2022-07-15","current":-10.938357,"twenty":-21.154154,"median":-8.623821,"eighty":-3.823859,"marketCap":598918791},{"date":"2022-07-22","current":-10.50788,"twenty":-21.113328,"median":-8.640812,"eighty":-3.827243,"marketCap":575348438},{"date":"2022-07-29","current":-10.529051,"twenty":-21.08161,"median":-8.648165,"eighty":-3.852269,"marketCap":576507636},{"date":"2022-08-05","current":-11.107725,"twenty":-21.062795,"median":-8.674304,"eighty":-3.89073,"marketCap":608192372},{"date":"2022-08-12","current":-11.044212,"twenty":-21.057369,"median":-8.686118,"eighty":-3.902788,"marketCap":604714779},{"date":"2022-08-19","current":-6.087169,"twenty":-21.027635,"median":-8.674304,"eighty":-3.912344,"marketCap":400919180},{"date":"2022-08-26","current":-5.735068,"twenty":-20.992994,"median":-8.648165,"eighty":-3.917696,"marketCap":377728757},{"date":"2022-09-02","current":-5.597808,"twenty":-20.953825,"median":-8.640812,"eighty":-3.930533,"marketCap":368688422},{"date":"2022-09-09","current":-5.520226,"twenty":-20.872033,"median":-8.630797,"eighty":-3.94283,"marketCap":363578668},{"date":"2022-09-16","current":-7.849101,"twenty":-20.73156,"median":-8.578381,"eighty":-3.96417,"marketCap":516965327},{"date":"2022-09-23","current":-8.510226,"twenty":-20.611725,"median":-8.513329,"eighty":-3.972574,"marketCap":560509001},{"date":"2022-09-30","current":-10.493601,"twenty":-20.565232,"median":-8.578381,"eighty":-3.993719,"marketCap":691140025},{"date":"2022-10-07","current":-10.198204,"twenty":-20.477427,"median":-8.630797,"eighty":-4.008882,"marketCap":671684341},{"date":"2022-10-14","current":-10.950762,"twenty":-20.387531,"median":-8.642079,"eighty":-4.009677,"marketCap":721250013},{"date":"2022-10-21","current":-11.562654,"twenty":-20.357199,"median":-8.654251,"eighty":-4.014693,"marketCap":761551073},{"date":"2022-10-28","current":-11.956516,"twenty":-20.32892,"median":-8.675551,"eighty":-4.030286,"marketCap":787491986},{"date":"2022-11-04","current":-12.005748,"twenty":-20.283001,"median":-8.686118,"eighty":-4.065307,"marketCap":790734600},{"date":"2022-11-11","current":-15.768029,"twenty":-20.180562,"median":-8.713449,"eighty":-4.079563,"marketCap":830439027},{"date":"2022-11-18","current":-16.115182,"twenty":-20.035419,"median":-8.773737,"eighty":-4.104617,"marketCap":848722157},{"date":"2022-11-25","current":-16.060368,"twenty":-20.023491,"median":-8.779267,"eighty":-4.104763,"marketCap":845835347},{"date":"2022-12-02","current":-16.425792,"twenty":-19.948284,"median":-8.800314,"eighty":-4.104763,"marketCap":865080747},{"date":"2022-12-09","current":-15.384334,"twenty":-19.937676,"median":-8.842235,"eighty":-4.115583,"marketCap":810231356},{"date":"2022-12-16","current":-15.39347,"twenty":-19.766046,"median":-8.880178,"eighty":-4.122926,"marketCap":810712491},{"date":"2022-12-23","current":-15.548775,"twenty":-19.620281,"median":-8.920409,"eighty":-4.130826,"marketCap":818891787},{"date":"2022-12-30","current":-16.599368,"twenty":-19.607217,"median":-8.936255,"eighty":-4.130945,"marketCap":874222313},{"date":"2023-01-06","current":-15.777165,"twenty":-19.59823,"median":-8.94733,"eighty":-4.146129,"marketCap":830920162},{"date":"2023-01-13","current":-17.101825,"twenty":-19.554345,"median":-9.043188,"eighty":-4.162328,"marketCap":900684738},{"date":"2023-01-20","current":-16.106046,"twenty":-19.478065,"median":-9.066475,"eighty":-4.171098,"marketCap":848241022},{"date":"2023-01-27","current":-15.420877,"twenty":-19.243528,"median":-9.155743,"eighty":-4.18158,"marketCap":812155896},{"date":"2023-02-03","current":-16.042097,"twenty":-18.988351,"median":-9.163635,"eighty":-4.19168,"marketCap":844873077},{"date":"2023-02-10","current":-16.416656,"twenty":-18.921278,"median":-9.21308,"eighty":-4.201222,"marketCap":864599612},{"date":"2023-02-17","current":-16.16086,"twenty":-18.818457,"median":-9.237619,"eighty":-4.208561,"marketCap":851127832},{"date":"2023-02-24","current":-15.567046,"twenty":-18.755454,"median":-9.279961,"eighty":-4.218427,"marketCap":819854057},{"date":"2023-03-03","current":-15.7863,"twenty":-18.713587,"median":-9.288903,"eighty":-4.239786,"marketCap":831401297},{"date":"2023-03-10","current":-12.695923,"twenty":-18.685623,"median":-9.337354,"eighty":-4.268913,"marketCap":744679346},{"date":"2023-03-17","current":-12.365944,"twenty":-18.625694,"median":-9.47488,"eighty":-4.277714,"marketCap":725324457},{"date":"2023-03-24","current":-11.450254,"twenty":-18.520909,"median":-9.51831,"eighty":-4.30099,"marketCap":671614641},{"date":"2023-03-31","current":-11.326512,"twenty":-18.333889,"median":-9.637448,"eighty":-4.31253,"marketCap":664356558},{"date":"2023-04-06","current":-11.343011,"twenty":-18.288121,"median":-9.673933,"eighty":-4.318821,"marketCap":665324302},{"date":"2023-04-14","current":-11.433755,"twenty":-18.224659,"median":-9.699267,"eighty":-4.318821,"marketCap":670646896},{"date":"2023-04-21","current":-12.012005,"twenty":-18.140723,"median":-9.745723,"eighty":-4.318821,"marketCap":704564136},{"date":"2023-04-28","current":-17.665967,"twenty":-18.140723,"median":-9.757173,"eighty":-4.324014,"marketCap":1036197283},{"date":"2023-05-05","current":-18.5444,"twenty":-18.345331,"median":-9.795122,"eighty":-4.333623,"marketCap":1087721785},{"date":"2023-05-12","current":-17.975574,"twenty":-18.548481,"median":-9.809491,"eighty":-4.342105,"marketCap":1227408161},{"date":"2023-05-19","current":-17.7789,"twenty":-18.385145,"median":-9.923908,"eighty":-4.345574,"marketCap":1213978850},{"date":"2023-05-26","current":-18.14807,"twenty":-18.548481,"median":-10.050322,"eighty":-4.359142,"marketCap":1239186528},{"date":"2023-06-02","current":-20.069433,"twenty":-18.624,"median":-10.097881,"eighty":-4.366759,"marketCap":1370381033},{"date":"2023-06-09","current":-21.42026,"twenty":-18.679679,"median":-10.133562,"eighty":-4.369631,"marketCap":1462618218},{"date":"2023-06-16","current":-20.925237,"twenty":-18.866911,"median":-10.16981,"eighty":-4.375728,"marketCap":1428817014},{"date":"2023-06-23","current":-21.134993,"twenty":-18.937913,"median":-10.21543,"eighty":-4.380543,"marketCap":1443139558},{"date":"2023-06-30","current":-19.937075,"twenty":-19.13128,"median":-10.25893,"eighty":-4.382308,"marketCap":1361343322},{"date":"2023-07-07","current":-19.327719,"twenty":-19.403716,"median":-10.300042,"eighty":-4.384874,"marketCap":1319735326},{"date":"2023-07-14","current":-19.516534,"twenty":-19.527631,"median":-10.366739,"eighty":-4.396081,"marketCap":1332627944},{"date":"2023-07-21","current":-18.778441,"twenty":-19.516534,"median":-10.433806,"eighty":-4.40569,"marketCap":1282229526},{"date":"2023-07-28","current":-18.083261,"twenty":-19.456456,"median":-10.472595,"eighty":-4.425522,"marketCap":1234761248},{"date":"2023-08-04","current":-18.684034,"twenty":-19.430709,"median":-10.508916,"eighty":-4.445846,"marketCap":1275783217},{"date":"2023-08-11","current":-19.793943,"twenty":-19.456456,"median":-10.529051,"eighty":-4.466169,"marketCap":1467760467},{"date":"2023-08-18","current":-19.297154,"twenty":-19.516534,"median":-10.56417,"eighty":-4.47125,"marketCap":1430922557},{"date":"2023-08-25","current":-21.788862,"twenty":-19.594416,"median":-10.725698,"eighty":-4.489816,"marketCap":1615687698},{"date":"2023-09-01","current":-22.790203,"twenty":-19.620281,"median":-10.783103,"eighty":-4.508424,"marketCap":1689939110},{"date":"2023-09-08","current":-21.773337,"twenty":-19.662379,"median":-10.81952,"eighty":-4.516812,"marketCap":1614536513},{"date":"2023-09-15","current":-22.891113,"twenty":-19.937195,"median":-10.874844,"eighty":-4.541754,"marketCap":1697421810},{"date":"2023-09-22","current":-21.88201,"twenty":-20.044607,"median":-10.927771,"eighty":-4.55153,"marketCap":1622594806},{"date":"2023-09-29","current":-20.640037,"twenty":-20.232827,"median":-10.973642,"eighty":-4.576935,"marketCap":1530500032},{"date":"2023-10-06","current":-20.546889,"twenty":-20.307025,"median":-10.998264,"eighty":-4.587214,"marketCap":1523592923},{"date":"2023-10-13","current":-21.191163,"twenty":-20.399581,"median":-11.044212,"eighty":-4.596272,"marketCap":1571367088},{"date":"2023-10-20","current":-20.127723,"twenty":-20.430908,"median":-11.063294,"eighty":-4.598275,"marketCap":1492510937},{"date":"2023-10-27","current":-22.829497,"twenty":-20.455558,"median":-11.08551,"eighty":-4.599291,"marketCap":1692852872},{"date":"2023-11-03","current":-25.350703,"twenty":-20.512907,"median":-11.133626,"eighty":-4.606404,"marketCap":1879805335},{"date":"2023-11-10","current":-18.349717,"twenty":-20.534125,"median":-11.159417,"eighty":-4.623679,"marketCap":1893819287},{"date":"2023-11-17","current":-18.699474,"twenty":-20.512907,"median":-11.219301,"eighty":-4.647268,"marketCap":1929916591},{"date":"2023-11-24","current":-19.986078,"twenty":-20.508077,"median":-11.235768,"eighty":-4.660326,"marketCap":2062703104},{"date":"2023-12-01","current":-19.642567,"twenty":-20.498333,"median":-11.326512,"eighty":-4.691605,"marketCap":2027250394},{"date":"2023-12-08","current":-19.523899,"twenty":-20.469266,"median":-11.343011,"eighty":-4.703566,"marketCap":2015003094},{"date":"2023-12-15","current":-21.372612,"twenty":-20.485729,"median":-11.403123,"eighty":-4.710056,"marketCap":2205803131},{"date":"2023-12-22","current":-21.178997,"twenty":-20.539127,"median":-11.433755,"eighty":-4.725299,"marketCap":2185820695},{"date":"2023-12-29","current":-22.378161,"twenty":-20.560916,"median":-11.460738,"eighty":-4.752445,"marketCap":2309582881},{"date":"2024-01-05","current":-21.616192,"twenty":-20.635863,"median":-11.478255,"eighty":-4.774704,"marketCap":2230942325},{"date":"2024-01-12","current":-24.694637,"twenty":-20.763319,"median":-11.573996,"eighty":-4.807425,"marketCap":2548659433},{"date":"2024-01-19","current":-28.378521,"twenty":-20.874895,"median":-11.672989,"eighty":-4.871722,"marketCap":2928862002},{"date":"2024-01-26","current":-30.347082,"twenty":-20.925237,"median":-11.754932,"eighty":-4.928537,"marketCap":3132031295},{"date":"2024-02-02","current":-31.796601,"twenty":-20.995241,"median":-11.84903,"eighty":-5.022175,"marketCap":3281631848},{"date":"2024-02-09","current":-31.989395,"twenty":-21.094154,"median":-11.907283,"eighty":-5.032659,"marketCap":3301529459},{"date":"2024-02-16","current":-33.160435,"twenty":-21.134993,"median":-12.008876,"eighty":-5.086047,"marketCap":3422389019},{"date":"2024-02-23","current":-29.405371,"twenty":-21.18143,"median":-12.106086,"eighty":-5.094177,"marketCap":3321660162},{"date":"2024-03-01","current":-29.504379,"twenty":-21.252364,"median":-12.196466,"eighty":-5.100274,"marketCap":3332844203},{"date":"2024-03-08","current":-29.854208,"twenty":-21.362618,"median":-12.275201,"eighty":-5.134457,"marketCap":3372361147},{"date":"2024-03-15","current":-29.570385,"twenty":-21.39159,"median":-12.312278,"eighty":-5.167912,"marketCap":3340300230},{"date":"2024-03-22","current":-30.118229,"twenty":-21.456111,"median":-12.35282,"eighty":-5.193104,"marketCap":3402185256},{"date":"2024-03-28","current":-28.586905,"twenty":-21.586005,"median":-12.411316,"eighty":-5.211962,"marketCap":3229205423},{"date":"2024-04-05","current":-27.326204,"twenty":-21.698819,"median":-12.663882,"eighty":-5.224529,"marketCap":3086795302},{"date":"2024-04-12","current":-28.685913,"twenty":-21.801282,"median":-12.695915,"eighty":-5.23565,"marketCap":3240389464},{"date":"2024-04-19","current":-24.831203,"twenty":-21.90599,"median":-12.746573,"eighty":-5.260951,"marketCap":2804957470},{"date":"2024-04-26","current":-25.561122,"twenty":-21.970513,"median":-12.778856,"eighty":-5.33492,"marketCap":2887409933},{"date":"2024-05-03","current":-27.460667,"twenty":-22.002271,"median":-12.852662,"eighty":-5.443511,"marketCap":3101984415},{"date":"2024-05-10","current":-23.864016,"twenty":-22.106629,"median":-13.01501,"eighty":-5.504053,"marketCap":3075904561},{"date":"2024-05-17","current":-24.386628,"twenty":-22.316456,"median":-13.122963,"eighty":-5.514677,"marketCap":3143265660},{"date":"2024-05-24","current":-22.578036,"twenty":-22.408348,"median":-13.19089,"eighty":-5.517064,"marketCap":2910150846},{"date":"2024-05-31","current":-21.016071,"twenty":-22.408348,"median":-13.405255,"eighty":-5.517064,"marketCap":2708824416},{"date":"2024-06-07","current":-23.270938,"twenty":-22.480222,"median":-13.492753,"eighty":-5.517064,"marketCap":2999461067},{"date":"2024-06-14","current":-22.859895,"twenty":-22.573944,"median":-13.658594,"eighty":-5.526194,"marketCap":2946480428},{"date":"2024-06-21","current":-21.297929,"twenty":-22.578036,"median":-13.849482,"eighty":-5.550065,"marketCap":2745153997},{"date":"2024-06-28","current":-20.18224,"twenty":-22.604654,"median":-14.065248,"eighty":-5.737455,"marketCap":2601349404},{"date":"2024-07-05","current":-19.548058,"twenty":-22.604654,"median":-14.207014,"eighty":-5.875249,"marketCap":2519607846},{"date":"2024-07-12","current":-25.833502,"twenty":-22.663386,"median":-14.56294,"eighty":-6.158782,"marketCap":3329757590},{"date":"2024-07-15","current":-26.081274,"twenty":-22.683944,"median":-14.611833,"eighty":-6.204137,"marketCap":3361693680},{"date":"2024-08-02","current":-27.685273,"twenty":-22.729538,"median":-15.101131,"eighty":-7.080248,"marketCap":3568437841},{"date":"2024-08-09","current":-20.650678,"twenty":-22.791755,"median":-15.174216,"eighty":-7.173892,"marketCap":3174814544},{"date":"2024-08-16","current":-20.941919,"twenty":-22.791755,"median":-15.356928,"eighty":-7.243187,"marketCap":3219589736},{"date":"2024-08-23","current":-21.062812,"twenty":-22.791755,"median":-15.420877,"eighty":-7.280035,"marketCap":3238175665},{"date":"2024-08-30","current":-21.524403,"twenty":-22.791755,"median":-15.493961,"eighty":-7.318659,"marketCap":3309140119},{"date":"2024-09-06","current":-20.53528,"twenty":-22.791755,"median":-15.548775,"eighty":-7.330832,"marketCap":3157073430},{"date":"2024-09-13","current":-19.842894,"twenty":-22.791755,"median":-15.658402,"eighty":-7.386643,"marketCap":3050626748},{"date":"2024-09-20","current":-19.386799,"twenty":-22.791755,"median":-15.731487,"eighty":-7.41883,"marketCap":2980507108},{"date":"2024-09-27","current":-16.76013,"twenty":-22.791755,"median":-15.7863,"eighty":-7.470507,"marketCap":2576685567},{"date":"2024-10-04","current":-16.073239,"twenty":-22.791755,"median":-15.877656,"eighty":-7.496684,"marketCap":2471083699},{"date":"2024-10-11","current":-16.595276,"twenty":-22.791755,"median":-15.923334,"eighty":-7.600254,"marketCap":2551341118},{"date":"2024-10-18","current":-16.864537,"twenty":-22.791755,"median":-15.959877,"eighty":-7.641123,"marketCap":2592737050},{"date":"2024-10-25","current":-16.045763,"twenty":-22.791755,"median":-16.042097,"eighty":-7.711567,"marketCap":2466859624},{"date":"2024-10-31","current":-16.188637,"twenty":-22.791755,"median":-16.087775,"eighty":-7.784511,"marketCap":2488824813},{"date":"2024-11-08","current":-14.552491,"twenty":-22.793308,"median":-16.087775,"eighty":-7.860776,"marketCap":2592089652},{"date":"2024-11-15","current":-14.300163,"twenty":-22.793308,"median":-16.087775,"eighty":-7.961667,"marketCap":2547145116},{"date":"2024-11-22","current":-12.907511,"twenty":-22.793308,"median":-16.087775,"eighty":-8.046396,"marketCap":2299085853},{"date":"2024-11-29","current":-13.276297,"twenty":-22.793308,"median":-16.087775,"eighty":-8.103024,"marketCap":2364774020},{"date":"2024-12-06","current":-12.795905,"twenty":-22.793308,"median":-16.087775,"eighty":-8.12743,"marketCap":2279206539},{"date":"2024-12-13","current":-12.50961,"twenty":-22.793308,"median":-16.087775,"eighty":-8.178203,"marketCap":2228211778},{"date":"2024-12-20","current":-12.029218,"twenty":-22.793308,"median":-16.087775,"eighty":-8.232893,"marketCap":2142644297},{"date":"2024-12-27","current":-12.54843,"twenty":-22.793308,"median":-16.087775,"eighty":-8.272654,"marketCap":2235126322},{"date":"2025-01-03","current":-12.208758,"twenty":-22.793308,"median":-16.087775,"eighty":-8.306032,"marketCap":2174624062},{"date":"2025-01-10","current":-12.058333,"twenty":-22.79486,"median":-16.087775,"eighty":-8.349042,"marketCap":2147830205},{"date":"2025-01-17","current":-11.024761,"twenty":-22.79486,"median":-16.087775,"eighty":-8.387198,"marketCap":1963730473},{"date":"2025-01-24","current":-11.301351,"twenty":-22.79486,"median":-16.087775,"eighty":-8.421336,"marketCap":2012996598},{"date":"2025-01-31","current":-11.587645,"twenty":-22.79486,"median":-16.087775,"eighty":-8.512709,"marketCap":2063991360},{"date":"2025-02-07","current":-11.626465,"twenty":-22.79486,"median":-16.087775,"eighty":-8.629402,"marketCap":2070905904},{"date":"2025-02-14","current":-6.537248,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1794324147},{"date":"2025-02-21","current":-6.930226,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1902187506},{"date":"2025-02-28","current":-6.455028,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1771756793},{"date":"2025-03-07","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-03-14","current":-6.046805,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1659708933},{"date":"2025-03-21","current":-5.880964,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1614189490},{"date":"2025-03-28","current":-5.558851,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1525776725},{"date":"2025-04-04","current":-4.965652,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1362957177},{"date":"2025-04-11","current":-5.029437,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1380464656},{"date":"2025-04-17","current":-5.160196,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1416354986},{"date":"2025-04-25","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-05-02","current":-6.528381,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1791890393},{"date":"2025-05-09","current":-5.185048,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1592240087},{"date":"2025-05-16","current":-4.936919,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1516043779},{"date":"2025-05-23","current":-5.327651,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1636031068},{"date":"2025-05-30","current":-5.718383,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1756018358},{"date":"2025-06-06","current":-6.01785,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1847979419},{"date":"2025-06-13","current":-6.354393,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1951326135},{"date":"2025-06-20","current":-6.234607,"twenty":-22.797965,"median":-16.087775,"eighty":-8.644345,"marketCap":1914541711},{"date":"2025-06-27","current":-6.357245,"twenty":-22.797965,"median":-16.087775,"eighty":-8.623821,"marketCap":1952201955},{"date":"2025-07-03","current":-6.303056,"twenty":-22.797965,"median":-16.087775,"eighty":-8.578381,"marketCap":1935561382},{"date":"2025-07-11","current":-6.5027,"twenty":-22.797965,"median":-16.087775,"eighty":-8.537547,"marketCap":1996868756},{"date":"2025-07-18","current":-6.300204,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1934685562},{"date":"2025-07-25","current":-7.081669,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2174660141},{"date":"2025-08-01","current":-6.94477,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2132620799},{"date":"2025-08-08","current":-5.919479,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1964095003},{"date":"2025-08-15","current":-6.437202,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2135876627},{"date":"2025-08-22","current":-6.50588,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2158663986},{"date":"2025-08-29","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-05","current":-6.822853,"twenty":-22.800061,"median":-16.094245,"eighty":-8.503193,"marketCap":2263836409},{"date":"2025-09-12","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-19","current":-6.92587,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2298017446},{"date":"2025-09-26","current":-6.785873,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2251566293},{"date":"2025-10-03","current":-7.184731,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2383908259},{"date":"2025-10-10","current":-7.076432,"twenty":-22.797965,"median":-16.087775,"eighty":-8.426063,"marketCap":2347974347},{"date":"2025-10-17","current":-7.314162,"twenty":-22.797965,"median":-16.087775,"eighty":-8.383627,"marketCap":2426853665},{"date":"2025-10-24","current":-7.506988,"twenty":-22.797965,"median":-16.087775,"eighty":-8.36786,"marketCap":2490833556},{"date":"2025-10-31","current":-8.346967,"twenty":-22.797965,"median":-16.087775,"eighty":-8.39891,"marketCap":2769540477},{"date":"2025-11-07","current":-16.280273,"twenty":-22.797965,"median":-16.115182,"eighty":-8.446927,"marketCap":2616842278},{"date":"2025-11-14","current":-17.354717,"twenty":-22.797965,"median":-16.176647,"eighty":-8.45396,"marketCap":2789545102},{"date":"2025-11-21","current":-18.085556,"twenty":-22.797965,"median":-16.210617,"eighty":-8.45396,"marketCap":2907018089},{"date":"2025-11-28","current":-19.427247,"twenty":-22.797965,"median":-16.280273,"eighty":-8.45396,"marketCap":3122677452},{"date":"2025-12-05","current":-19.639954,"twenty":-22.797965,"median":-16.315109,"eighty":-8.45396,"marketCap":3156867352},{"date":"2025-12-12","current":-18.303718,"twenty":-22.797965,"median":-16.365703,"eighty":-8.45396,"marketCap":2942084652},{"date":"2025-12-19","current":-18.140097,"twenty":-22.797965,"median":-16.416656,"eighty":-8.45396,"marketCap":2915784730},{"date":"2025-12-26","current":-19.459971,"twenty":-22.797965,"median":-16.47147,"eighty":-8.45396,"marketCap":3127937437},{"date":"2026-01-02","current":-18.854574,"twenty":-22.797965,"median":-16.52495,"eighty":-8.45396,"marketCap":3030627724},{"date":"2026-01-09","current":-19.869024,"twenty":-22.797965,"median":-16.599368,"eighty":-8.45396,"marketCap":3193687243},{"date":"2026-01-16","current":-19.667225,"twenty":-22.797965,"median":-16.654182,"eighty":-8.45396,"marketCap":3161250672},{"date":"2026-01-23","current":-19.743581,"twenty":-22.797965,"median":-16.776759,"eighty":-8.45396,"marketCap":3173523969},{"date":"2026-01-30","current":-17.992838,"twenty":-22.797965,"median":-16.864537,"eighty":-8.45396,"marketCap":2892114799},{"date":"2026-02-06","current":-17.327447,"twenty":-22.797965,"median":-16.944631,"eighty":-8.45396,"marketCap":2785161782},{"date":"2026-02-13","current":-17.191096,"twenty":-22.797965,"median":-16.997091,"eighty":-8.45396,"marketCap":2763245180},{"date":"2026-02-20","current":-25.410135,"twenty":-22.829497,"median":-17.067857,"eighty":-8.45396,"marketCap":2889081488},{"date":"2026-02-27","current":-24.63779,"twenty":-22.859895,"median":-17.238205,"eighty":-8.45396,"marketCap":2801267461},{"date":"2026-03-06","current":-25.510539,"twenty":-22.975694,"median":-17.398349,"eighty":-8.45396,"marketCap":2900497311},{"date":"2026-03-13","current":-25.356071,"twenty":-23.059318,"median":-17.427264,"eighty":-8.45396,"marketCap":2882934506},{"date":"2026-03-20","current":-25.178431,"twenty":-23.145422,"median":-17.532711,"eighty":-8.45396,"marketCap":2862737280},{"date":"2026-03-27","current":-24.784536,"twenty":-23.270938,"median":-17.545608,"eighty":-8.45396,"marketCap":2817952126},{"date":"2026-04-02","current":-25.08575,"twenty":-23.407723,"median":-17.545608,"eighty":-8.45396,"marketCap":2852199596},{"date":"2026-04-10","current":-23.94268,"twenty":-23.579678,"median":-17.545608,"eighty":-8.45396,"marketCap":2722234837},{"date":"2026-04-17","current":-25.10892,"twenty":-23.717857,"median":-17.696952,"eighty":-8.45396,"marketCap":2854834017},{"date":"2026-04-24","current":-23.710977,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2695890628},{"date":"2026-05-01","current":-22.475225,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2555388185}],"updateTime":1777717115138},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDYA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168624894","title":"IDEAYA Biosciences將於五月啓動RTOR申請，新藥上市申請預計2026年下半年完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1168624894","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168624894?lang=zh_tw&edition=fundamental","pubTime":"2026-04-30 18:11","pubTimestamp":1777543916,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布，公司计划于今年五月启动实时肿瘤学审评（RTOR）提交程序。这一重要举措标志着其候选药物开发进入关键阶段。\n根据最新时间表，IDEAYA Biosciences预计将在2026年下半年完成新药上市申请（NDA）的提交工作。该时间节点的确立为后续商业化进程奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627413276","title":"美國研究綜述-百健、Equinix、Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627413276","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627413276?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 15:46","pubTimestamp":1776152774,"startTime":"0","endTime":"0","summary":"美国研究综述-百健、Equinix、Revolution Medicines路透4月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括百健、Equinix 和 Revolution Medicines。要闻 * 百健BIIB.O：Piper Sandler将其评级从中性上调至增持 * Equinix Inc EQIX.O：杰富瑞将目标价从1,000美元上调至1,220美元 * Revolution Medicines Inc RVMD.O：Raymond James将目标价从135美元上调至175美元 * SBA Communications Corp SBAC.O：杰富瑞将目标价从182美元上调至213美元 * Williams Companies Inc WMB.N：Raymond James将目标价从73美元上调至78美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4S40X0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRA","ADGM","BEX","CPB","AVB","BL","MSFU","MAA","MRNX","MRNA","BIIB","EQIX","MSFT","NEO","ADPT","TREE","EXR","CAG","HUBS","BEG","BE","JAN","DLR","SJM","CPT","PODD","BRBR","GIS","CAI","WGS","KHC","MSFO","LNG","MRNY","HSY","MKC","BEZ","MSFX","IDYA","INSP","BDX","BSX","MSFW","NSA","FLS","GH","ASAN","CUBE","MSFD","CBRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627279413","title":"美國研究綜述-百健、Equinix、Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627279413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627279413?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 15:46","pubTimestamp":1776152774,"startTime":"0","endTime":"0","summary":"美国研究综述-百健、Equinix、Revolution Medicines路透4月14日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括百健、Equinix 和 Revolution Medicines。要闻 * 百健BIIB.O：Piper Sandler将其评级从中性上调至增持 * Equinix Inc EQIX.O：杰富瑞将目标价从1,000美元上调至1,220美元 * Revolution Medicines Inc RVMD.O：Raymond James将目标价从135美元上调至175美元 * SBA Communications Corp SBAC.O：杰富瑞将目标价从182美元上调至213美元 * Williams Companies Inc WMB.N：Raymond James将目标价从73美元上调至78美元以下是路透周二报导的美国公司研究报告摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4T40X0LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","NEO","CPT","CPB","MSFT","BEG","CAG","BEX","BEZ","MKC","KHC","BSX","AVB","FLS","IDYA","LNG","PODD","MRNA","BE","JAN","MSFW","MSFY","HSY","INSP","MSFO","ADPT","DLR","ASAN","EQIX","GIS","CUBE","MSFL","HUBS","WGS","MSFD","MAA","BIIB","BRBR","NTRA","SJM","GH","TREE","MSFX","EXR","BL","NSA","BDX","CAI","ADGM","CBRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627045446","title":"BUZZ--美國股票走勢-Allogene Therapeutics、Adobe、Williams-Sonoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627045446","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627045446?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 23:45","pubTimestamp":1776095125,"startTime":"0","endTime":"0","summary":"nL6N40W0G6 ** Ocular Therapeutix Inc OCUL.O:BUZZ - 由于新眼药显示疾病控制时间更长而上涨 nL4N40W0TJ ** Spyre Therapeutics Inc SYRE.O:BUZZ - 因肠道疾病药物中期研究成功而上涨 nL6N40W0OH ** Alphabet Inc GOOGL.O：** Meta Platforms Inc META.O：** Snap Inc SNAP.N：** Pinterest Inc PINS.N：BUZZ - 因地缘政治动荡和能源价格，Stifel 下调数字广告增长预期 nL4N40W0RX ** ImageneBio Inc IMA.O:BUZZ--为资助脱发和皮肤病药物融资 3,000 万美元后股价上涨 nL4N40W0UI ** 国际商业机器公司IBM.N：BUZZ - 花旗集团开始对 IBM 进行 \"买入 \"评级。nL6N40W0O3 ** Best Buy Co Inc BBY.N:BUZZ - 因高盛将其评级双双下调至 \"卖出 \"而下滑。nL6N40W0RY ** Revolution Medicines Inc RVMD.O:BUZZ - 因胰腺癌药物","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4T40W1DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMA","CAG","DIOD","HTFL","TFX","CVX","RVMD","WSM","IBM","OCUL","ANIP","REPL","APTV","MARA","SYRE","RIOT","DOW","IDYA","BIIB","LYB","AAL","HPE","KYMR","EMN","HL","LUV","OWL","XOM","GPRO","META","CDE","DAL","NEM","HUT","DVN","ADBE","ALLO","SNDK","CRWV","AVT","PINS","OXY","BBY","LEG","GOOGL","UAL","COIN","GGLS","SBUX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179626267","title":"IDEAYA Biosciences飆漲逾40%！因眼癌藥物組合試驗達到主要目標並計劃提交新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1179626267","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179626267?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 18:38","pubTimestamp":1776076736,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences今日盘前股价大幅上涨31.15%，引起了市场的广泛关注。独立中心影像评估确认，该组合疗法在主要疗效指标——中位无进展生存期方面展现出具有统计学意义的显著改善。具体数据显示，联合治疗组的中位生存期提高了6.9个月，而对照组仅为3.1个月，并且观察到了完全缓解病例。基于这些积极数据，公司计划在2026年下半年向美国食品药品监督管理局提交新药申请，寻求加速批准路径。","market":"sg","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"136b75c5fc6d3e3cb6dd1c794553aeae","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"IDEAYA Biosciences飙涨逾40%！因眼癌药物组合试验达到主要目标并计划提交新药申请","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431105","title":"BUZZ-眼癌藥物組合在試驗中提高了存活率，IDEAYA 生物科學公司股價大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431105","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431105?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 18:19","pubTimestamp":1776075570,"startTime":"0","endTime":"0","summary":"** 截至上一交易日收盘，IDYA股价累计下跌11.8%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"136b75c5fc6d3e3cb6dd1c794553aeae","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4S40W0O0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU0306807586.USD","BK4139","LU0456855351.SGD","SG9999001176.USD","LU1894683264.USD","SG9999003800.SGD","IE000M9KFDE8.USD","BK4581","LU0225771236.USD","SG9999002224.SGD","BK4550","LU1057294990.SGD","LU0225284248.USD","LU1883839398.USD","LU0321505439.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4534","BK4533","LU0321505868.SGD","SG9999002232.USD","LU0289739699.SGD","SG9999011175.SGD","LU1066053197.SGD","LU0058720904.USD","SGXZ57979304.SGD","LU1023059063.AUD","BK4568","IE00BLSP4239.USD","BK4585","BK4592","IDYA","SG9999013999.USD","LU0306806265.USD","LU1894683348.USD","SG9999001176.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00BLSP4452.SGD","LU0868494617.USD","LU0234572021.USD","BK4007","BK4599","LU0122379950.USD","BK4588","IE00BBT3K403.USD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178706059","title":"IDEAYA與施維雅公布Darovasertib聯合克唑替尼一線治療HLA-A*02:01陰性轉移性葡萄膜黑色素瘤的2/3期註冊試驗（OPTIMUM-02）積極頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1178706059","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178706059?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 18:07","pubTimestamp":1776074841,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences与施维雅联合宣布，其针对Darovasertib与克唑替尼组合疗法用于一线治疗HLA-A*02:01阴性转移性葡萄膜黑色素瘤的2/3期注册临床试验（OPTIMUM-02）取得积极顶线结果。该突破性进展标志着转移性葡萄膜黑色素瘤治疗领域迈出关键一步，为缺乏HLA-A*02:01基因型的患者群体提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431352","title":"Ideaya眼癌藥物達到中後期試驗的主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431352","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431352?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 18:05","pubTimestamp":1776074710,"startTime":"0","endTime":"0","summary":"Ideaya眼癌药物达到中后期试验的主要目标路透4月13日 - Ideaya Biosciences IDYA.O周一表示，其治疗一种眼癌的药物达到了中后期试验的主要目标，患者的生存率得到了改善，且疾病未进展。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"136b75c5fc6d3e3cb6dd1c794553aeae","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4S40W0MT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100785826","title":"IDEAYA Biosciences計劃於2026年下半年提交新藥申請 支持美國加速審批路徑","url":"https://stock-news.laohu8.com/highlight/detail?id=1100785826","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100785826?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 18:01","pubTimestamp":1776074476,"startTime":"0","endTime":"0","summary":"生物制药公司IDEAYA Biosciences宣布，其针对关键研发项目的新药申请（NDA）时间表已正式确立——公司计划在2026年下半年向美国食品药品监督管理局（FDA）提交申报材料，旨在通过加速审批通道推动创新疗法早日上市。\n这一战略部署凸显了IDEAYA在肿瘤靶向治疗领域的研发进展与监管策略的协同推进。若获批，加速审批机制将显著缩短药物从临床验证到商业化的周期，为存在未满足医疗需求的患者提供更及时的治疗选择。\n公司管理层表示，此次NDA提交计划基于现有临床数据包的积极结果与后续试验设计，具体申报范围将随研发里程碑的达成而进一步明确。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175431474","title":"IDEAYA Biosciences臨床試驗達到主要終點 BICR評估顯示中位無進展生存期實現統計學顯著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1175431474","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175431474?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 18:01","pubTimestamp":1776074474,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布其临床试验成功达到主要研究终点。经独立中心影像评估确认，该研究在主要疗效指标——中位无进展生存期方面展现出具有统计学意义的显著改善。\n这一突破性进展标志着公司在靶向疗法开发领域取得重要里程碑，为后续临床开发计划的推进奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119778358","title":"IDEAYA Biosciences將於2026年4月13日公布轉移性葡萄膜黑色素瘤II/III期Optimum-02試驗頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1119778358","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119778358?lang=zh_tw&edition=fundamental","pubTime":"2026-04-11 04:06","pubTimestamp":1775851578,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布，公司计划于2026年4月13日（星期一）正式公布其针对转移性葡萄膜黑色素瘤的II/III期Optimum-02临床试验的顶线结果。这一关键数据的披露备受业界关注，或将直接影响公司未来研发策略与市场布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148847126","title":"IDEAYA Biosciences與阿斯利康達成臨床合作 共同推進IDE849聯合Imfinzi治療小細胞肺癌研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1148847126","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148847126?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 18:24","pubTimestamp":1775730286,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences Inc于2026年4月8日宣布与阿斯利康制药达成临床合作协定。根据美国证券交易委员会披露文件，双方将针对IDEAYA研发的IDE849与阿斯利康的Imfinzi联合疗法，开展针对广泛期小细胞肺癌的临床评估。根据协议安排，IDEAYA将作为临床试验的申办方，主导研究推进；阿斯利康则负责提供其抗PD-L1抗体Imfinzi。此次与阿斯利康的强强联合，有望加速该药物在难治性肿瘤领域的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640478417.SGD","LU1989771016.USD","LU0757432116.USD","LU0047473722.SGD","LU0171293334.USD","LU0266013472.USD","LU2468319806.SGD","LU2089283258.USD","LU2114397693.USD","LU0972486137.USD","LU1119994496.HKD","LU0887340254.USD","LU2279689827.SGD","LU0496365809.HKD","LU0211327993.USD","LU0949170426.SGD","LU2433249047.HKD","LU1989772923.USD","LU2293690249.USD","LU1481599808.USD","LU1015430645.USD","LU0661504455.SGD","LU0345777147.USD","LU0011850046.USD","LU1267930573.SGD","LU0857590862.USD","LU0557290698.USD","LU1496350171.SGD","LU2125909247.SGD","LU0203345920.USD","LU2091194634.USD","LU0957799991.USD","LU1983299246.USD","LU1078025761.USD","03165","LU1057294990.SGD","LU1301847155.USD","IDYA","LU0432979614.USD","LU1323610961.USD","LU0310800379.SGD","LU0882574055.USD","LU0114720955.EUR","LU2355687059.USD","LU0203347892.USD","LU0969580561.USD","LU1267930813.SGD","LU2324357040.USD","LU2023251221.USD","LU0784385840.USD","LU0052756011.USD","LU1061106388.HKD","LU1153585028.USD","LU1267930227.SGD","LU0963555726.SGD","LU1153584641.USD","LU2089284900.SGD","LU2293690082.USD","LU1019632923.USD","LU0949170772.SGD","IE00BKPKM643.USD","LU0158827948.USD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU0784383803.USD","LU0211328371.USD","LU1104425308.USD","LU1261432733.SGD","SG9999013999.USD","LU1923622614.USD","LU2089984988.USD","LU1003076772.USD","LU0827474353.SGD","LU1046234339.USD","LU1196032939.SGD","IE00BFTCPJ56.SGD","LU0545039389.USD","LU1084165304.USD","LU0526926950.USD","LU0499090636.EUR","LU0920783379.SGD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU1023059063.AUD","LU1267930490.SGD","LU0920840948.USD","LU0976567544.SGD","LU0345777659.USD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0964806797.USD","LU1880407215.USD","LU0889565080.SGD","LU0784385170.HKD","AZN.UK","LU0058720904.USD","LU0823416689.USD","LU0997586515.USD","LU2108987350.USD","LU0738911758.USD","LU0823399737.USD","BK4139","LU1064927863.SGD","LU0390134368.USD","LU0211326839.USD","LU0047473722.EUR","LU0211326755.USD","LU0128525929.USD","LU0128525689.USD","BK5011","IE0002141913.USD","LU1880407132.USD","IE0009355771.USD","IE00B2B36J28.USD","LU0310800965.SGD","LU1273509221.SGD","LU0310799852.SGD","LU1496350502.SGD","LU2125909593.SGD","LU0029864427.USD","LU1814569148.SGD","LU2112291526.USD","LU0997586432.USD","LU2539964713.USD","LU0960981461.USD","LU2133065610.SGD","IE00B3T34201.USD","LU0889566641.SGD","LU1481600234.SGD","IE0034235188.USD","LU0077335932.USD","LU0784384876.USD","LU1003077747.HKD","LU1487256676.USD","LU0553294199.USD","LU1989772840.SGD","LU1019634622.SGD","LU1170363599.USD","LU0708994859.HKD","LU1051770623.HKD","LU0792757196.USD","SG9999001176.SGD","LU0122379950.USD","LU0575583348.USD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626183449","title":"BUZZ-與阿斯利康達成肺癌藥物組合測試協議後，IDEAYA 公司股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2626183449","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626183449?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 18:15","pubTimestamp":1775729757,"startTime":"0","endTime":"0","summary":"BUZZ-与阿斯利康达成肺癌药物组合测试协议后，IDEAYA 公司股价上涨4月9日 - ** 生物技术公司IDEAYA BiosciencesIDYA.O的股价盘前上涨2%至31.50美元** 该公司表示，它将与阿斯利康的AZN.LImfinzi一起在广泛期小细胞肺癌患者中测试其实验性药物IDE849，小细胞肺癌是一种扩散速度快的侵袭性肺癌。** IDYA公司表示，IDE849还将在一项全球早期研究中用于其他难以治疗的癌症，包括某些神经内分泌肿瘤和黑色素瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4T40S0QN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0887340254.USD","LU2539964713.USD","LU0972486137.USD","LU1814569148.SGD","LU0949170772.SGD","LU0882574055.USD","LU0757432116.USD","LU0211326839.USD","LU1267930813.SGD","LU0211327993.USD","03165","LU2133065610.SGD","LU0047473722.EUR","LU0964806797.USD","IE00BJJMRZ35.SGD","LU2091194634.USD","LU0128525689.USD","IE0009355771.USD","LU0211328371.USD","LU0960981461.USD","LU2279689827.SGD","LU1015430645.USD","IE00BFTCPJ56.SGD","LU0047473722.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU1301847155.USD","LU0920840948.USD","LU1078025761.USD","LU1153585028.USD","LU0553294199.USD","LU1481600234.SGD","LU0575583348.USD","LU0266013472.USD","IDYA","SG9999001176.SGD","LU0889565080.SGD","AZN.UK","LU0310800379.SGD","LU0128525929.USD","LU0823416689.USD","LU1291159041.SGD","LU1880407215.USD","LU0738911758.USD","LU1003077747.HKD","LU2089284900.SGD","LU0499090636.EUR","LU0708994859.HKD","LU0640478417.SGD","LU0526926950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166712162","title":"IDEAYA Biosciences推進Ide849針對Dll3上調實體瘤的全球一期臨床試驗——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1166712162","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166712162?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 18:07","pubTimestamp":1775729236,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences公司正在积极推进其候选药物Ide849针对Dll3上调实体瘤的全球一期临床试验。这一研发进展已通过美国证券交易委员会的文件正式披露。该试验旨在评估Ide849在Dll3表达上调的各类实体瘤患者中的安全性、耐受性及初步疗效。此次全球一期临床试验的推进，标志着IDEAYA Biosciences在精准肿瘤学领域的研究取得重要阶段性成果。公司将继续依托其深厚的靶向治疗研发平台，探索Ide849为特定患者群体提供新的治疗选择的可能性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174843416","title":"IDEAYA Biosciences 達成協議 評估Ide849聯合Imfinzi治療廣泛期小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1174843416","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174843416?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 18:07","pubTimestamp":1775729235,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences公司宣布，已签署一项临床合作协议，旨在评估其研发的候选药物Ide849与阿斯利康的Imfinzi（度伐利尤单抗）联合疗法，用于治疗广泛期小细胞肺癌（ES-SCLC）患者。\n该研究将探索这种联合疗法的安全性、耐受性及初步疗效，为后续的临床开发提供关键数据依据。广泛期小细胞肺癌是一种侵袭性强、治疗选择有限的恶性肿瘤，此项合作有望为该患者群体带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625706796","title":"BUZZ--美國股票走勢-泰森食品公司、Atmus 過濾公司、安飛士預算公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2625706796","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625706796?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 23:45","pubTimestamp":1775490340,"startTime":"0","endTime":"0","summary":"nL6N40P0AM ** Playtika Holding Corp PLTK.O:BUZZ - 在宣布审查战略备选方案后上涨 nL4N40P0GB ** Nvidia Corp NVDA.O：** Advanced Micro Devices Inc AMD.O：** 高通公司 QCOM.O：** Broadcom Inc AVGO.O:BUZZ - 行业组织称，2月份全球芯片销售额猛增62%。nL4N40P0JM ** Praxis Precision Medicines Inc PRAX.O:BUZZ - 因癫痫药物减少儿童癫痫发作而上涨 nL4N40P0NM ** Tyson Foods Inc TSN.N:BUZZ - Piper Sandler将Tyson Foods的评级提升至 \"增持\"。nL6N40P0E7 ** Atmus Filtration Technologies Inc ATMU.N:BUZZ--该公司将加入标准普尔小型股指数，股价上涨。nL6N40P0E2 ** Oncolytics Biotech Inc ONCY.O:BUZZ - 因该公司计划与美国食品及药物管理局就肛门癌药物进行谈判而上涨。nL4N40P0PL ** Carvana Co CVNA.N:BUZZ - 因美国银行将宏观","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nL4T40P0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDQ","RKT","BKNU","NVD3.UK","NVDB","AVGG","DVN","IBRX","ATMU","AMYY","SLNO","QCOM","BKNG","AMDY","ADM","CVX","LGN","KTOS","CVNA","NVDA","WTBA","WLK","AMDW","AGPU","IDYA","VLO","NVD2.UK","ANV","XOM","NVDX","KTUP","AVGO","AMD","CAR","OXY","AVGW","NVDY","PRAX","DOW","AMDL","PFSA","ELAB","FAF","NVIW.SI","ONCY","EXPE","AESI","TSN","DAMD","LYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625679348","title":"BUZZ--美國股票走勢-Soleno Therapeutics、Ideaya Biosciences、Profusa","url":"https://stock-news.laohu8.com/highlight/detail?id=2625679348","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625679348?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 19:57","pubTimestamp":1775476628,"startTime":"0","endTime":"0","summary":"nL6N40P0AG ** Kratos Defense & Security Solutions Inc KTOS.O:BUZZ - 因增长潜力被杰富瑞上调至 \"买入 \"后上涨 nL4N40P0G2 ** Rocket Companies Inc RKT.N：** First American Financial Corp FAF.N：BUZZ--巴克莱银行在Rocket和First American回调后将其评级提升至 \"增持\"。nL6N40P0AM ** Playtika Holding Corp PLTK.O:BUZZ - 在宣布审查战略备选方案后上涨 nL4N40P0GB ** Nvidia Corp NVDA.O：** Advanced Micro Devices Inc AMD.O：** 高通公司 QCOM.O：** Broadcom Inc AVGO.O:BUZZ - 行业组织称，2月份全球芯片销售额猛增62%。nL4N40P0HU ** Neurocrine Biosciences ** Soleno Therapeutics BUZZ - Nuerocrine达成29亿美元收购交易，Soleno跳涨 nL4N40P0GZ (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nL4S40P0K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COP","FANG","NVD3.UK","DAMD","NVII","XOMZ","PSX","NVDU","OXY","RKTL","NVDB","NVDG","NVD2.UK","RKT","AVGX","PLTK","NBIX","IDYA","SNVD.UK","NVDA","NVDX","XOMO","BKR","PFSA","DIPS","FAF","NVDL","QCOM","AVGO","AVGW","2NVD.UK","AVGU","CVX","NVDS","NVDW","KTOS","WTBA","NVDQ","NVDS.UK","SLB","XOMX","DVN","NVD","NVDO","SLNO","AVGG","AVL","XOM","MPC","AMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625758366","title":"BUZZ-早期癌症試驗啓動，IDEAYA 生物科學公司上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2625758366","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625758366?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 18:19","pubTimestamp":1775470767,"startTime":"0","endTime":"0","summary":"BUZZ-早期癌症试验启动，IDEAYA 生物科学公司上涨4月6日 - ** 生物技术公司IDEAYA BiosciencesIDYA.O股价盘前上涨1.3%至33.12美元** 公司表示，已招募首位患者参与IDE574的早期试验，这是一种治疗实体瘤或在乳腺、肺、前列腺和结肠等器官中形成肿块的癌症的实验性药片。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nL4S40P0FT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105775904","title":"IDEAYA Biosciences宣佈啓動Ide574一期臨床試驗首例患者給藥，該潛在首創雙效抑制劑靶向乳腺癌、前列腺癌、結直腸癌及肺癌等多類實體瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1105775904","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105775904?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 18:01","pubTimestamp":1775469715,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences宣布，其潜在首创双效抑制剂Ide574针对Kat6/7靶点的一期临床试验已完成首例患者给药。该药物旨在治疗包括乳腺癌、前列腺癌、结直肠癌和肺癌在内的多种实体瘤适应症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623631226","title":"BUZZ--美國股票走勢-能源股、礦商、Sysco","url":"https://stock-news.laohu8.com/highlight/detail?id=2623631226","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623631226?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 20:00","pubTimestamp":1774872051,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL4T40I12K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0788109394.HKD","LU2506951958.HKD","LU0238689110.USD","LU1582987324.SGD","LU2324357040.USD","LU2265009873.SGD","SG9999014575.USD","LU2211817866.USD","LU0161305163.EUR","LU2646069778.SGD","GFI","LU2462611646.USD","LU0912757837.SGD","LU1023059493.AUD","LU0788109121.HKD","LU0320765489.SGD","LU0795875086.SGD","IE0009355771.USD","LU0256863811.USD","LU1582986359.USD","BK4585","LU0345770993.USD","LU0170899867.USD","IE00B2Q91V27.USD","LU1267930813.SGD","LU1929549753.HKD","LU1804176565.USD","SGXZ57979304.SGD","LU0208291251.USD","LU0496367417.USD","BK4522","LU1496350171.SGD","LU1989764664.SGD","BK4124","AU","LU0433182093.SGD","LU0345780281.USD","LU0251132253.USD","LU1668664300.SGD","LU0466842654.USD","LU0070217475.USD","LU0345769128.USD","LU1291159041.SGD","LU0345780521.USD","LU0047473722.SGD","BK4533","LU0724618789.USD","NWMX","LU0417517546.SGD","LU1582987597.SGD","LU1066051498.USD","LU0300736062.USD","BK4532","IE0034235303.USD","BK4592","LU0130518102.USD","BK5152","LU1116320901.HKD","BK4570","LU0122379950.USD","LU0630314457.HKD","LU2087625088.SGD","SG9999014559.SGD","LU2430703178.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","XOMO","LU1035777561.USD","LU0942090050.USD","LU2244417387.USD","LU0787776722.HKD","LU0048578792.EUR","LU1078025761.USD","LU0882574055.USD","APTV","LU1064927863.SGD","CENX","LU2506951875.HKD","LU1496350502.SGD","BSX","NEM","BK4139","LU0612318971.USD","KALU","LU1023059063.AUD","LU1791807156.HKD","LU0498741890.SGD","LU0055631609.USD","NEMG","LU0330918003.SGD","BK4534","IE00BJJMRZ35.SGD","LU2357305700.SGD","LU0987226296.USD","LU1732799900.SGD","LU0498741114.HKD","LU1223083913.SGD","LU1791710582.SGD","LU2362541513.USD","LU0300736492.USD","SG9999014567.USD","LU1989764748.USD","AA","LU0320765646.SGD","LU1430597077.USD","LU0985489474.SGD","LU1778281490.HKD","LU0345777659.USD","LU0278409577.USD","BK4153","LU0612318385.USD","BK4082","LU1983299246.USD","SG9999001143.SGD","BK4566","LU2362540622.SGD","LU2506952170.USD","LU0823417653.USD","ADMA","LU0075056555.USD","LU2129689605.HKD","LU2133065610.SGD","LU0823416689.USD","SG9999015358.SGD","LU0648000940.SGD","LU2129689514.USD","LU1989772840.SGD","LU0683600562.USD","LU2592432038.USD","HMY","LU1150488218.USD","LU0265550946.USD","LU0171281750.USD","LU1989771016.USD","SG9999001176.SGD","LU2491049909.HKD","LU0266512127.USD","IE00BGHQF524.EUR","LU1116320737.USD","IE00B7SZLL34.SGD","LU0143863784.USD","LU0477156797.USD","SG9999013999.USD","BK4581","LU0256331488.USD","LU0432979614.USD","ALV","SG9999001176.USD","LU2430703095.HKD","LU1868838027.USD","XOMX","LU0114720955.EUR","LU1366192091.USD","LU1201861165.SGD","LU1223082196.USD","LU2237438978.USD","LU2430703251.USD","LU0098860793.USD","LU1162221912.USD","LU0795875169.SGD","LU2242652126.USD","SG9999002521.SGD","LU2491050071.SGD","LU2498475776.HKD","LU0345769631.USD","BK4201","LU2129689431.USD","LU1989772923.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IDYA","LU0203345920.USD","LU1153585028.USD","LU1868837565.USD","LU2347655156.SGD","LU1066053197.SGD","LU1061106388.HKD","LU1489326972.SGD","LU2505996509.AUD","IE0002141913.USD","IE00BWXC8680.SGD","IE000M9KFDE8.USD","LU0047473722.EUR","LU0267386448.USD","LU1057294990.SGD","LU1548497426.USD","LU2242646821.SGD","LU0345777147.USD","LU0266013472.USD","XOMZ","LU0868494708.USD","BK4504","LU0265550359.USD","LU2381873111.SGD","BK4588","LU1791710400.SGD","LU0889566641.SGD","ZYME","LU2505996681.GBP","LU1674673691.USD","LU1023061473.USD","LU1732800096.USD","LU2125154778.USD","LU2506952097.USD","SG9999014542.SGD","LU0550127509.SGD","LU0143863198.USD","LU1023061713.HKD","LU1989763427.SGD","LU2360032135.SGD","LU0068578508.USD","LU1280957306.USD","LU0203347892.USD","LU2125154935.USD","LU0077335932.USD","LU0345780950.USD","IE00BKDWB100.SGD","LU0964806797.USD","SG9999002224.SGD","LU0654597011.USD","LU2543165471.USD","DVN","BK4550","LU0997586606.USD","SYY","LU1894683264.USD","LU0187121727.USD","LU2087621335.USD","LU0225283273.USD","IE00B1XK9C88.USD","LU2362541273.HKD","LU2602419157.SGD","BK4516","LU1150488135.SGD","LU1720051017.SGD","LU0266512473.USD","LU0640476718.USD","LU0368265764.SGD","LU2242649171.HKD","LU1720051108.HKD","BK4017","LU0048584097.USD","LU1883866441.USD","LU0353189763.USD","LU0122376428.USD","BK4102","LU1074936037.SGD","LU1989763690.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0868494617.USD","IE00B3T34201.USD","LU0106831901.USD","LU1718418525.SGD","LU0345781412.USD","LU0788108826.HKD","LU1582986433.USD","IE00B3CCJ963.GBP","IE00B4R5TH58.HKD","LU0011850046.USD","IE00B2B36J28.USD","LU0130103400.USD","LU0823417737.USD","LU0070302665.USD","IE00BFXG1179.USD","LU0950375773.USD","LU0345770308.USD","LU0878866978.SGD","LU0353189680.USD","LU1839511570.USD","BK4559","LU1894683348.USD","LU0792757196.USD","IE0002270589.USD","ADNT","LU0456854461.SGD","SG9999002232.USD","LU0528227936.USD","SG9999015341.SGD","LU0149725797.USD","LU0234572021.USD","LU1223082519.USD","LU2491050154.USD","LU0368265418.SGD","LU1674673428.USD","BK4213"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}